The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells
about
Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cellsAntigen-specific tolerance in immunotherapy of Th2-associated allergic diseases.Restoring immune tolerance in neuromyelitis optica: Part IManipulating regulatory T cells: a promising strategy to treat autoimmunityThe role of the PD-1 pathway in autoimmunity and peripheral toleranceCharacterization of immunogenic properties of haptenated liposomal model membranes in mice. II. Induction of delayed-type hypersensitivityMolecular mechanisms of T-cell receptor and costimulatory molecule ligation/blockade in autoimmune disease therapy.Intrinsic and induced regulation of the age-associated onset of spontaneous experimental autoimmune encephalomyelitisTherapeutic blockade of T-cell antigen receptor signal transduction and costimulation in autoimmune diseaseBlocking costimulatory signals to induce transplantation tolerance and prevent autoimmune disease.Immunotherapy of type 1 diabetes: where are we and where should we be going?Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: implications for the pathogenesis of multiple sclerosis.TGF-beta-induced myelin peptide-specific regulatory T cells mediate antigen-specific suppression of induction of experimental autoimmune encephalomyelitis.Host-etiological agent interactions in intranasally and intraperitoneally induced Cryptococcosis in miceEthylenecarbodiimide-treated splenocytes carrying male CD4 epitopes confer histocompatibility Y chromosome antigen transplant protection by inhibiting CD154 upregulation.Nasal tolerance induction as a potential means of immunotherapy for autoimmune diseases: implications for clinical medicine.Murine herpes simplex virus keratitis is accentuated by CD4+, V beta 8.2+ Th2 T cellsPolymeric synthetic nanoparticles for the induction of antigen-specific immunological toleranceAntigen-specific tolerance as a therapy for experimental autoimmune encephalomyelitis.Tolerance induced by apoptotic antigen-coupled leukocytes is induced by PD-L1+ and IL-10-producing splenic macrophages and maintained by T regulatory cells.Epitopes and idiotypes in experimental autoimmune uveitis: a review.Peripherally Induced Tolerance Depends on Peripheral Regulatory T Cells That Require Hopx To Inhibit Intrinsic IL-2 Expression.Harnessing nanoparticles for immune modulationInduction of immunoglobulin allotypic suppression in the rabbit: a cellular approach.A small hypervariable segment in the variable domain of an immunoglobulin light chain stimulates formation of anti-idiotypic suppressor T cells.Suppressor T-cell mechanisms in contact sensitivity. III. Apparent non-major histocompatibility complex restriction is a result of multiple sets of major histocompatibility complex-specific suppressor T cells induced by syngeneic 2,4-dinitrophenyl-mSuppression of idiotype and generation of suppressor T cells with idiotype-conjugated thymocytes.Antigen- and receptor-driven regulatory mechanisms. II. Induction of suppressor T cells with idiotype-coupled syngeneic spleen cellsAntigen-specific T cell-mediated suppression. V. H-2-linked genetic control of distinct antigen-specific defects in the production and activity of L-glutamic acid50-L-tyrosine50 suppressor factor.Antigen- and receptor-driven regulatory mechanisms. V. The failure of idiotype-coupled spleen cells to induce unresponsiveness in animals lacking the appropriate VH genes is caused by the lack of idiotype-matched targetsAntigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivoFunctional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitisRegulatory T cells in lupus.Autoantigen-specific immunosuppression with tolerogenic peripheral blood cells prevents relapses in a mouse model of relapsing-remitting multiple sclerosis.ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms.Novel autoantigens for diabetogenic CD4 T cells in autoimmune diabetes.Exploiting apoptosis for therapeutic tolerance induction.Prospects for antigen-specific tolerance based therapies for the treatment of multiple sclerosisAntigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis
P2860
Q26851647-D1BA0670-BAA5-468D-A9C2-5289663BA0F0Q27687250-8B124FDA-920D-4E18-A000-1B14FEE346ACQ28072382-15299A4D-4CBB-438F-84C0-9FE1DAFFB5CEQ28083298-4F9E208E-2231-4617-88C3-133DEDA953E6Q28304161-1540FAB2-0AD2-4E1E-947D-73703ACE657FQ28365832-CEA4F230-6DA8-4D12-8D59-8FA490F5FD34Q33753720-4C018E5D-9C1B-4F2E-A0B2-02AA498FF5E3Q33784281-131B4AF2-26B2-471E-8BDE-2FAFCC5A76CBQ33785953-808D776B-CE5B-4208-82DB-B9D7BDFCD91DQ33805849-5439302D-8CDD-4212-9346-40574B398AFBQ33815506-268A4216-427D-4446-9102-783255682102Q33843431-13784C5F-21F3-42C6-9C79-805F0B6C64EFQ33901013-27C6A4CD-4974-4963-A93A-667A4FE2A63FQ33906829-292ABE95-810A-43FA-87F7-CE851871757BQ34103866-9F666430-5A02-4AA7-BE42-56B9F650FB04Q34106906-4F71EB65-827A-4FD8-AFDB-65827137843DQ34163966-7C4F3021-D867-4A5F-B1BD-E458FF441C1BQ34985424-BFA53442-8341-4770-9D41-E53B6B1F6542Q35173096-4B4E82D2-AF8E-4526-8663-580FF51BAB76Q35175866-5FAD0854-44EC-4513-A013-F7951CA7158EQ35482896-7443FC6F-DD71-4839-9D77-CA255F3A3CC1Q35931454-97B565F1-5AF3-4AB8-9086-DAB64EF4DCC3Q36154772-CC1FCC1C-B1EF-4254-B657-AC07D3377607Q36259689-915A1E9A-C041-4864-9EE2-604D2FB0347DQ36311069-F2B64CAA-A403-4EFA-B1CD-B586CFBD1F10Q36342808-8B81669E-E8BB-4E39-A7B8-CE47C10C84CAQ36342862-AD3FE931-1232-48B8-BB99-13245CD520F6Q36342991-2D1E18C2-B428-4B08-8017-732ABD894332Q36343557-27AA4153-2F14-4404-AD3E-3C3B574B84B9Q36344150-02EDF006-0BB7-46B3-948C-54331C6DC8C9Q36353340-4BD8DDCF-AC8F-408D-8CD3-7D27254D56ADQ36365105-06DBCFD1-C5D7-477F-9E69-8FD535C07DA9Q36419022-0778FBA9-B7C0-4FE6-A554-018E15DA85E7Q36854682-352909BB-2C8D-4C88-B506-F3A511EAE07AQ36936238-33B1CBBE-FD96-4EBA-9371-9567CF9AEDF3Q37018598-4426CFF0-1F0B-42F0-AF9D-3D50AB092BF6Q37353657-7EF1A13D-827E-4A34-8AEE-69584424EA1BQ37364480-2ADE677C-E733-429F-9DEC-949CDA225751Q37650497-3A4D7AED-9335-45A6-8465-4363ED9E52CBQ37679881-2366E9BD-D209-4119-82A2-4448AD0B4B03
P2860
The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells
description
1979 nî lūn-bûn
@nan
1979年の論文
@ja
1979年学术文章
@wuu
1979年学术文章
@zh-cn
1979年学术文章
@zh-hans
1979年学术文章
@zh-my
1979年学术文章
@zh-sg
1979年學術文章
@yue
1979年學術文章
@zh
1979年學術文章
@zh-hant
name
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@ast
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@en
type
label
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@ast
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@en
prefLabel
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@ast
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@en
P2093
P2860
P356
P1476
The induction of cell-mediated ...... ed to syngeneic lymphoid cells
@en
P2093
P2860
P304
P356
10.1084/JEM.149.3.758
P407
P577
1979-03-01T00:00:00Z